Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation‐induced thromboxane B 2 and lipopolysaccharide‐induced prostaglandin E 2 were measured ex vivo and in vitro in human whole blood as indices of COX‐1 and COX‐2 activity. In vitro , acetaminophen elicited a 4.4‐fold selectivity toward COX‐2 inhibition (IC 50 = 113.7 μmol/L for COX‐1;IC 50 = 25.8 μmol/L for COX‐2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX‐1) and 83% (COX‐2). Acetaminophen plasma concentrations remained above the in vitro IC 50 for COX‐2 for at least 5 h postadministration. Ex vivo IC 50 values (COX‐1: 105.2 μmol/L; COX‐2: 26.3 μmol/L) of acetaminophen compared favorably with its in vitro IC 50 values. In contrast to previous concepts, acetaminophen inhibited COX‐2 by more than 80%, i.e. , to a degree comparable to nonste‐roidal antiinflammatory drugs (NSAIDs) and selective COX‐2 inhibitors. However, a >95% COX‐1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX‐2 inhibition, recently defined cardiovascular warnings for use of COX‐2 inhibitors should also be considered for acetaminophen.—Hinz, B., Cheremina, O., Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB J. 22, 383–390 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hinz et al. (2007) demonstrated 4.4x more selectivity toward the inhibition of COX-2 (IC 50 = 25.8 µmol/L) over COX-1 (IC 50 = 113.7 µmol/ L) from in vitro assays using whole human blood [51].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“In this study, paracetamol demonstrated over 80% blockade of COX-2 activity comparable to NSAIDs and COX-2 selective inhibitors.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“It is not clear why there are significant discrepancies in relation to inhibition of COX-1 and COX-2 activities by paracetamol as reported by Hinz et al. [51] and Mitchell et al. [33].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 2×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
The antioxidants of human extracellular fluids
Halliwell, B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,341 · cited 1×
“Thus, the presence of various enzymatic and nonenzymatic antioxidant components in human plasma (33) may explain why acetaminophen elicited the most pronounced COX-2 inhibition in human whole blood as compared to the two other experimental systems.”
ResultSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“Apart from these factors, evidence for COX-2 inhibition by acetaminophen is also supported by previous findings showing that acetaminophen like indomethacin and aspirin confers the synthesis of 18R-hydroxyeicosapentaenoic acid (HEPE) and 15RHEPE through interaction with the COX-2 enzyme (34).”
ResultLangenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123 · cited 1×
“A COXindependent mechanism for the gastrointestinal toxicity of NSAIDs is further supported by findings in COX-1 knockout mice, which still develop gastric erosions in response to oral administration of indomethacin (45).”
BackgroundPharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807 · cited 2×
“A peripheral antiinflammatory action is further supported by findings showing acetaminophen as an inhibitor of nociception and edema in the rat carrageenan footpad model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 2×
“Whereas the drug was first associated with a predominant suppression of PG synthesis in brain tissue ( 3 ), subsequent studies contradicted a cell-specific modulation (4 –7).”
BackgroundMethodMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 4×
“Moreover, it turned out that acetaminophen elicits no measurable inhibition of PG formation in broken cell preparations but a profound suppression in intact cells (7).”
BackgroundInfluentialNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 522 · cited 1×
“PGE2 is the currently most plausible explanation for the cardiovascular hazard conferred by selective and nonselective COX-2 inhibitors (20, 30).”
Background
Research works printed but not linked: 1
- Mantzke U. S., 2002, Paracetamol in childhood. Current state of knowledge and indications for a rational approach to postoperative analgesia, Anaesthesist, 51, 735
Cited by
Items 401–489 of 489
Sudano, I., Flammer, A. J., Périat, D., Enseleit, F., Hermann, M., Wolfrum, M., Hirt, A., Kaiser, P., Hürlimann, D., Holzmeister, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.027185
Role of Intravenous Acetaminophen in Postoperative Pain Management
Groudine, S. B., Smith, H. S., & Ellsworth, D. (2012) · Pain Management · doi:10.2217/pmt.12.50
Uppu, B., Muppur, A., & Devi.B, V. (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-131233338
“Non steroidal anti inflammatory drugs (NSAIDS)(2) are drugs with analgesic, antipyretic, and anti inflammatory effects .”
BackgroundInfluentialFracon, R. N. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.58.2009.tde-30082010-103722
Micro-Pharmacokinetics by Finger-Prick: Acetaminophen
Schloss, J. V., & Marshall, B. M. (2015) · Cited by 1
Interacción dexibuprofeno con paracetamol en formalina orofacial experimental
Góngora, C. B. (2009) · Universidad de Chile
Yang, Y.-M. (2014) · Rehabilitation practice and science · doi:10.6315/2014.42(3)04
The transition from acute to chronic post-surgical pain – A prospective cohort study
MacLachlan, C. (2016) · Otago University Research Archive (University of Otago) · Cited by 1
Simpson, M. G. (2010) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
The pharmacotherapy of low back pain
Greeff, O. B. W. (2018) · South African Family Practice · doi:10.4102/safp.v60i1.4816
Yousef, M. M., Helal, O. K., & Adly, N. (2011) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000407615.77259.7a
Doleman, B., Read, D. J., Lund, J. N., & Williams, J. P. (2016) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000396
Gump, B. S., McMullan, D. R., Cauthon, D. J., Whitt, J. A., Mundo, J. D. D., Letham, T., Kim, P. J., Friedlander, G. N., Pingel, J., Langberg, H., et al. (2013)
MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach
Rieswijk, L. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160120lr
Moreno, M. G., Cano, J. A., Torres-Aguilar, Y., Quintero-García, M. A., & García, J. A. A. (2015) · Anales Médicos de la Asociación Médica del Centro Médico ABC · Cited by 2
Heart Involvement in Osteoarthritis
Courties, A., & Sellam, J. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00019-3
Nichtopioidanalgetika in der Anästhesiologie
Brack, A., & Schäfer, M. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-54507-2_21
Formulation of microcomposites and pastilles using spray-drying and melt technology
Katona, G. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.3983
Takeda, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-08613-2_31-1 · Cited by 1
Prospective observational study on peri-operative usage pattern of analgesics
Saha, S., Chakraborty, S., Chatterjee, T. K., Bandyopadhyay, A. K., Ray, S., & Chakraborty, J. (2016)
Over-the-counter drugs and non-febrile thermoregulation: is there cause for concern?
Foster, J. (2017) · University of Bedfordshire Repository (University of Bedfordshire)
Production sélective et directionnelle des prostaglandines dans l'endomètre
Lacroix‐Pepin, N. (2014)
Sabuncuoğlu, F. A., Erşahan, Ş., Amasyali, M., & Avunduk, M. C. (2018) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000005000 · Cited by 1
“44 For example, a recent study carried out with human volunteers showed that acetaminophen promotes >80% inhibition of peripheral COX-2, which is a rate comparable to that of selective NSAIDs.45 Acemetacin is a carboxymethyl ester derivative of indomethacin,8 an NSAID with nonselective inhibition of COX-1 and COX-2.”
BackgroundFlaherty, J., Elliot, C., & Wardhan, R. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190856649.003.0009
COMPARATIVE QUALITY EVALUATION OF TWO BRANDS OF PARACETAMOL TABLETS OBTAINED FROM THE MARKET
Khan, A. D. (2019) · INTERNATIONAL JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH (IJPER) · doi:10.37021/ijper.v1i1.14
Çaparlar, C. Ö. (2019) · Haydarpasa Numune Training and Research Hospital Medical Journal · doi:10.14744/hnhj.2019.67044
Therapie myofaszialer Schmerzsyndrome
(2011) · Elsevier eBooks · doi:10.1016/b978-3-437-23095-0.10004-5
Immune-to-Brain Signaling in Fever : The Brain Endothelium as Interface
Mirrasekhian, E. (2020) · Linköping University medical dissertations · doi:10.3384/diss.diva-168711
Effekt von Paracetamol auf den Blutdruck bei Patienten mit koronarer Herzkrankheit
Sudano, Roas, Flammer, A. J., Noll, & Ruschitzka (2012) · Praxis · doi:10.1024/1661-8157/a000963
Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part One.
Pizzorno, J. E., & Pizzorno, L. (2021) · PubMed · Cited by 1
Limavady, A., Dwi Aris Agung, N., & Purnomo, E. (2018)
Eicosanoid turnover in GtoPdb v.2021.3
Izzo, A. A., & Mitchell, J. A. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f243/2021.3
Neuropeptides in the RVM Promote Descending Facilitation and Abnormal Pain
Marshall, T. M. (2008) · UA Campus Repository (The University of Arizona)
Cyclooxygenases in Biology and Disease
Botting, R. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-28753-4_976
(2013) · Acta Medicinae et Sociologica · doi:10.19055/ams.2013.4/11/3
Therapeutic Agents for the Treatment of Migraine
Dubowchik, G. M., & Macor, J. E. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc244
Essenzielle schmerztherapeutische Aspekte
(2022) · Schmerz Nachrichten · doi:10.1007/s44180-022-00020-3
COX‐2‐Hemmer: Keine präventive Wirkung gegen Hautkrebs
Yen, H., Yen, H., Drucker, A. M., Han, J., Li, W., Li, T., Qureshi, A. A., & Cho, E. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14649_g
(2015) · Elsevier eBooks · doi:10.1016/b978-3-437-23671-6.00006-7
Therapie myofaszialer Schmerzsyndrome
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23097-4.00004-x
Schmerztherapie mit Nicht-Opioiden
Beubler, E. (2016) · Springer eBooks · doi:10.1007/978-3-662-48827-0_3
Isales, C. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734281983.793557754
Continuing Professional Development: Pain management for paramedic practice
(2013) · Journal of Paramedic Practice · doi:10.12968/jpar.2013.5.6.cpd1
Schmerztherapie mit Nicht-Opioiden
(2009) · Springer eBooks · doi:10.1007/978-3-211-79269-8_6
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00006-8
Takeda, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-08359-9_31
Detection of the analgesic effect of ceftriaxone in chicks
Othman, I. K., & Alzubadaidy, M. H. (2022) · Annals of the College of Medicine Mosul/Annals of the College of Medecine · doi:10.33899/mmed.2022.133399.1141
Schrör, K. (2022) · De Gruyter eBooks · doi:10.1515/9783110746419-002
Schmerztherapie beim Patienten mit Hufrehe
Hopster, K. (2022) · pferde spiegel · doi:10.1055/a-1879-2219
“So sollte der COX-3-Weg diese Diskrepanz erklären, aber neuere Studien lassen es als unwahrscheinlich erscheinen, dass er beim Menschen eine größere Rolle spielt und es werden alternative Erklärungsmodelle vorgeschlagen [2].”
BackgroundData from Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women
Gates, M. A., Tworoger, S. S., Eliassen, A. H., Missmer, S. A., & Hankinson, S. E. (2023) · doi:10.1158/1055-9965.c.6515092.v1
Iodine-Promoted Transamidation of N,N-Dimethylacetamide (DMA) with Amines
Ma, H., Zhou, F., Su, F., Han, B., Li, R., Zhang, Y., & Wang, J. (2023) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202304022
Strategies to Overcome Metabolic Syndrome and Related Diseases
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5556-9
Jones, J. E., Konsoula, Z., Williamson, L. L., Anderson, R., Meza-Keuthen, S., & Parker, W. (2025) · Preprints.org · doi:10.20944/preprints202501.0319.v3
KCNQ Kanalak eta Parazetamola: Epilepsiaren Tratamendurako Aukera Bat?
Núñez, E., M‐Alicante, S., Sanchez, N., Urrutia, J., Muguruza‐Montero, A., Ibarluzea, M. G., & Villarroel, Á. (2025) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.27126
Książek, T. K., Szeliga, A., Dembicki, P. M., Francuziak, A. E., Kozłowska, K., Borowski, M., Dzieszko, N., Szczepański, M., Kalinowska, W., & Kulasza, P. S. (2025) · Quality in Sport · doi:10.12775/qs.2025.43.61483
Autism, or Pathologised Evolution?Preprint
Chambers, A. (2025) · doi:10.14293/pr2199.002072.v1
Jones, J. E., Konsoula, Z., Williamson, L. L., Anderson, R., Meza-Keuthen, S., & Parker, W. (2025) · Preprints.org · doi:10.20944/preprints202501.0319.v5
Risks and Benefits of Nonsteroidal Anti-inflammatory Drugs in the Hemostatic System
Cignarella, A., Campello, E., Ramaschi, G. E., Simion, C., & Simioni, P. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2725-6989 · Cited by 3
“In general”
Management of Influenza‐Like Syndromes: Expert Consensus on the Use of Paracetamol
Grattagliano, I., Andreoni, M., Cattelan, A. M., Aprile, P. L., Rossi, A., & Parrella, R. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/4880395
“Paracetamol has higher selectivity for COX-2 over COX-1 and lacks substantial peripheral anti-infammatory activity, as it inhibits prostaglandin synthesis at the peroxidase site of COX enzymes, rather than the cyclooxygenase site, which is characteristic of NSAIDs [11, 12].”
Jones, J. E., Konsoula, Z., Williamson, L. L., Anderson, R., Meza-Keuthen, S., & Parker, W. (2025) · Preprints.org · doi:10.20944/preprints202501.0319.v4
Samtidig bruk av warfarin og smertestillende legemidler
Pettersen, M. H. (2008) · NORA - Norwegian Open Research Archives
DeYoung, E. (2012) · e-Publications@Marquette (Marquette University)
Majer, J. (2023) · ORCA Online Research @Cardiff (Cardiff University)
REVIEW: HYPERACUSIS, ANIMAL MODELS, CHRONIC STRESS, AND AUTISM IN FRAGILE X
Salvi, R., Chen, Y.-C., & Auerbach, B. D. (2025) · Journal of Hearing Science · doi:10.17430/jhs/204553
“These results suggest that other drugs with a pharmacologic profile similar to salicylate (e.g. COX inhibitor AKR1C1) might be tested with these procedures to determine if they induce hyperacusis [89,90].”
Thongsuwan, P., Nahar, L., Sarker, S. D., Karin, B., Phosri, C., & Suwannasai, N. (2026) · Annals of Microbiology · doi:10.1186/s13213-025-01838-2
“For example, p -acetamidophenol is known for its anti-inflammatory and antimicrobial properties (Hinz et al. 2008; Ahmad et al. 2016); istamycin C1 and netilmicin are aminoglycoside antibiotics (Ikeda et al. 1982; Campoli-Richards et al. 1989); spiromesifen has pesticidal properties (Cerda-Apresa…”
Amzoiu, D. C., Ciocîlteu, M.-V., Amzoiu, E., Abou-Khalil, S., Popescu, S., Taisescu, O., & Rău, G. (2025) · Journal of Science and Arts · doi:10.46939/j.sci.arts-25.4-b03
Toxicidad cardiovascular y renal de los antiinflamatorios no esteroideos
Alfie, J. (2009) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v29i1.1057
Thongsuwan, P., Nahar, L., Sarker, S. D., Kongmaung, P., Choowongkomon, K., Phosri, C., & Suwannasai, N. (2026) · Journal of Fungi · doi:10.3390/jof12020093
“These compounds are associated with diverse pharmacological functions such as analgesic, antimicrobial, cytotoxic, and surfactant activities [29,31,33,34], suggesting that X. thienhirunae SWUF17-44.”
Sobolewski, C. (2011) · theses.fr (ABES) · doi:10.70675/e72700b2z059cz41e7z9859z70fa3f9ceb04 · Cited by 1
Rôle de la voie COX-2 au cours de l'infection par Brucella
Gagnaire, A. (2016) · theses.fr (ABES) · doi:10.70675/2f54eb87za0e5z4e1dzb465z168c5d1054de
Duong, T. T. M. (2016) · theses.fr (ABES) · doi:10.70675/a3fc9563zfabez48ffzb3f3zd2544d626f9b
Formulation and Evaluation of Orodispersible Tablets Containing Paracetamol and Ibuprofen
AlQashi, Z., Alahmad, S., Salah, S., & Hejaz, H. A. (2025) · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal · doi:10.59049/2790-0231.12.1.2638
Stromer, W., Crevenna, R., Likar, R., Müller, E., & Machacek, P. (2026) · Schmerz Nachrichten · doi:10.1007/s44180-026-00280-3
Hyperacusis-inducing drug candidates
Salvi, R., Wang, T.-C., & Eddins, A. C. (2026) · Hearing Research · doi:10.1016/j.heares.2026.109673
Amzoiu, D. C., Taisescu, O., Popescu, S., Amzoiu, E., Ciocîlteu, M.-V., Manda, C. V., Abou-Khalil, S., Anoaica, P. G., & Rău, G. (2026) · Journal of Science and Arts · doi:10.46939/j.sci.arts-26.2-b02
Alongo, M. M., Agasa, S. B., Otuli, N. L., Sihalikyolo, J.-J. J., Mayindu, S. M., Ilongosi, B. A., Bahaisi, L. B., Kadima, J. N., & Bosunga, K. (2026) · BMC Immunology · doi:10.1186/s12865-026-00875-z
“…acting analgesic and antipyretic agent with only weak anti-inflammatory activity [52], and even at a full 1000 mg dose its cyclooxygenase inhibition is functionally COX-2-selective while sparing the COX-1-depen-dent peripheral pathways governing platelet and gastric prostaglandin synthesis [53].”
Siddiqui, M. M. R., Ahammed, T., Hossain, M. A., Taztufa, J., & Bushra, F. J. (2026) · International Journal of Orthopaedics and Physiotherapy · doi:10.33545/26648989.2026.v8.i2a.53
Tsuchiya, H., Takai, Y., & Mizogami, M. (2026) · Medical Principles and Practice · doi:10.1159/mpp/adpag006
“Based on COX-2 inhibition in human whole blood assays [22–26, 28– COX-1 IC 50 in human whole blood assays [22, 24–26, 28, 30–34] ranged from 42 μmol/L to > 100 μmol/L for acetaminophen, whereas 0.08–7.6 μmol/L for zalto-profen, meloxicam, diclofenac, ibuprofen, loxoprofen, ketoprofen, and…”
InfluentialJin, J., Liu, T., Wang, L., Jiao, T., Yu, H., Wang, C., & Zhang, H. (2026) · Crystal Growth & Design · doi:10.1021/acs.cgd.6c00768
Aminophenazone (amidopyrine): Historical analgesic with hematologic risk
Vadlapatla, R., Karimi, A., Shirazi, A., & Cho, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44037-3.00337-7
Ren, X., Xue, L., Wang, Y., & Xiao, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1833275
“Previous studies have shown that prophylactic administration of acetaminophen can limit vaccine responses in children (Hinz et al., 2008; Högestätt et al., 2005), leading the World Health Organization to recommend against its use before or during vaccination (Prymula et al., 2009).”
Schmerztherapie mit Nicht-Opioiden
Beubler, E. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1282-3_4
Metadata
- Authors
- Hinz, B., Cheremina, O., & Brune, K.
- Affiliations
- University of Rostock (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- ORCID
- Hinz, Burkhard
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-09-20
- Volume
- 22
- Issue
- 2
- Pages
- 383-390
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2132889863
- Cited by
- 478
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 19 · 2020: 14 · 2019: 28 · 2018: 33 · 2017: 29 · 2016: 35 · 2015: 49 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- paracetamol, COX-2 inhibition, COX-1 inhibition, COX-2 inhibitors, thromboxane B2, prostaglandin E2, plasma pharmacokinetics, gastrointestinal safety, cardiovascular risk, analgesic mechanism, anti-inflammatory mechanism
- MeSH terms
- Acetaminophen, Cells, Cultured, Humans, Isoenzymes, Monocytes, Time Factors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.